AzTrials
AzTrials

Critical IllnessNCT02247895

Treatment of Muscle Weakness in Critically Ill Patients

A study testing Electrical stimulation in people with Critical Illness and Respiratory Failure, run by Gerald Supinski at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Patients who are admitted to the intensive care unit and require mechanical ventilation frequently develop profound respiratory and limb muscle weakness. Studies show that the development of weakness during the ICU stay results in poor outcomes. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Critical Illness, Respiratory Failure, Myopathy
What is being tested?
Electrical stimulation
Type of treatment
Medical device
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
2 participants
Where
1 siteUnited States
Study dates
Dec 2016to Feb 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Acute respiratory failure requiring mechanical ventilation

Who cannot join

  • Attending physician on service determines that patient too unstable to tolerate measurements
  • Patient requires > 15mcg/min norepinephrine or > 15mg/kg/min of dopamine.
  • Fraction of inspired oxygen > 80% or positive end expiratory pressure > 15 cm H20 requirements.
  • Cardiac pacemaker or implanted defibrillator.
  • Neuromuscular blocking agents delivered within 48 hours of preceding testing.
  • Existing neuromuscular disease.
Show all 15Show fewer
  • Profound uncorrectable hypokalemia (< 2.5) OR hypophosphatemia (< 1.0)
  • Acute lower extremity deep vein thrombosis
  • Pregnancy
  • Prisoner
  • Institutionalized patient
  • If primary attending determines that patient is terminal and will likely have care withdrawn within 7 days
  • Do not resuscitate order
  • Body mass index > 40
  • Patients requiring mechanical ventilation more than 4 days prior to study entry

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Kentucky Medical Center

    Lexington, Kentucky, 40586

Other trials in United States

About this study

Official title: Effect of Treatment With the Niveus Medical Muscle Stimulation System 110 on Quadriceps Strength In Mechanically Ventilated Patients

Patients who are admitted to the intensive care unit and require mechanical ventilation frequently develop profound respiratory and limb muscle weakness. Studies show that the development of weakness during the ICU stay results in poor outcomes. Currently there are no treatments for this muscle weakness, but it has been suggested that this weakness might improve with physical therapy. Electrical stimulation is a method to provide direct stimulation to the muscles potentially enhancing function and improving strength. The purpose of this study is to test the hypothesis that neuromuscular electrical stimulation of the quadriceps muscle will improve muscle strength in patients who are critically ill on mechanical ventilation.

Read the detailed description

The basic study design is to:

  1. Obtain informed consent from patient or the patients LAR
  2. Randomize subjects to treatment with either:
  3. Sham therapy, consisting of bilateral placement of Niveus Medical Muscle Stimulation System 110 electrodes for 30 minutes twice daily without activation of the electrical circuitry of the unit, or
  4. Active therapy, using the Niveus Medical Muscle Stimulation System 110 electrodes to actively produce a rhythmic quadriceps contraction for 30 minutes twice daily
  5. Measure magnetic stimulated quadriceps twitch (QuadTw) strength bilaterally as well as ultrasound assessment of quadriceps size
  6. Continue sham or active treatment daily for 7 days for a total of 14 sessions
  7. Repeat measurements of magnetic stimulated QuadTw strength and ultrasound assessment of quadriceps size on Day 8 or before Day 8 if the subject is to be discharged from the hospital prior to the allotted duration of sham or active treatment
  8. Functional measurement of the patient using the Functional Status Score for the ICU (FSS-ICU) at the end of the treatment period or upon discharge
  9. A member of the research team will visit the subject until hospital discharge and will record total duration (days) of mechanical ventilation, duration (days) of mechanical ventilation following study entry, duration of ICU stay, ventilator weaning time (days measured from time of first spontaneous breathing trial to extubation), and total duration (days) of hospitalization
  10. The investigators will also review each subject's medical record on entry into the study to obtain demographic information including the following: age, sex, diagnoses, medications, reason for institution of mechanical ventilation, vital signs at the time of the initial visit, bedside parameters of mechanical ventilation use (including mode of ventilation, duration of ventilation, level of oxygen, breath volume and rate, % triggered breaths), most recent arterial blood gas values, and chest radiograph readings at the time of the initial visit. The investigators will also record the subject's weight, BMI and total intake and output values since admission to the ICU. In addition, investigators will monitor each subject's progress in the ICU daily by reviewing the subject's medical record and recording the clinical parameters as well as recording daily weights and total intake and output. These parameters will also be assessed until the time that the patient is discharged from the ICU. In addition, the investigators will record and note all physical therapy and occupational therapy sessions that the subject receives as part of the standard of care in the ICU and in the hospital up until the time of discharge. In the University of Kentucky hospital, occupational therapy records the Barthel Index at each session which uses a scale of 0-100 to assess an individual's functional independence when performing activities of daily living (ADLs). Physical therapy assesses functional status using Kansas University Hospital Physical Therapy Acute Care Functional Outcomes, which also assesses functional status in the categories of bed mobility, transfer, gait and walking distance.
Being tested
Sham Treatment, Electrical stimulation
Keywords
ICU Acquired weakness, Critical illness, Mechanical ventilation
Medical subject headings
Critical Illness, Respiratory Insufficiency, Muscular Diseases, Asthenia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Sham TreatmentDevice

    Also called Sham treatment without electrical stimulation

    Subjects will undergo the same protocol as the treatment group except no electrical stimulation will be applied.

  • Electrical stimulationDevice

    Two thirty minute sessions of neuromuscular electrical stimulation applied to both quadriceps for seven days for a total of 14 treatments

Study groups in NCT02247895
Study groupRoleWhat they receive
Sham TreatmentSham comparatorSham stimulation twice daily
Receives: Device: Sham Treatment
Active TreatmentActive comparatorThe active treatment group will receive neuromuscular electrical stimulation to both quadriceps muscle for 30 minutes twice daily for a total of 14 treatments.
Receives: Device: Electrical stimulation

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Technical Feasibility, that is ability to complete therapy sessions

    Percentage of patients who completed treatment with the device

    Measured: Discharge from ICU, Average 7-10 days

Secondary outcomes (5)
  1. Total ICU length of stay

    Average 7-10 days

    Measured: Discharge from ICU, Average 7-10 days

  2. Hospital Length of Stay

    Average 14-21 days

    Measured: Hospital discharge, Average 14-21 days

  3. Functional Status Score for ICU

    Average 7-10 days after study entry

    Measured: ICU discharge, Average 7-10 days after study entry

  4. Duration of mechanical ventilation after study entry

    Average 4-10 days

    Measured: Until patient is successfully weaned from mechanical ventilation, Average 4-10 days

  5. Change in quadriceps twitch force generation

    Quadriceps twitch force generation will be measured using magnetic stimulation of each femoral nerve and compared to measurements obtained at the time of study entry (baseline-prior to randomization)

    Measured: Baseline (prior to Treatment) and Day 8

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Sep 2014 (estimated)
  2. Study startDec 2016
  3. Primary completionFeb 2018
  4. Study completionFeb 2018

Why it stopped: difficulty meeting enrollment goals

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Device feasibility
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
2 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02247895
Sponsor's protocol ID
062014
Other IDs
14-0237-F3R
Status last verified
Jun 2020
First submitted
2 Sep 2014
Last updated
22 Jun 2020
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Electrical stimulation in people with Critical Illness and Respiratory Failure, run by Gerald Supinski at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 22 Jun 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: difficulty meeting enrollment goals). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Technical Feasibility, that is ability to complete therapy sessions (time frame: Discharge from ICU, Average 7-10 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in